Study Title: A Randomized Phase III Trial of Doxorubicin + Pembrolizumab Versus Doxorubicin Alone for the Treatment of Undifferentiated Pleomorphic Sarcoma (UPS) and Related Poorly Differentiated Sarcomas
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Christopher Rangel, at rangelc@musc.edu.Study Coordinator, Eva Newman, at newmanev@musc.edu.Trial opened at the following institutions: Medical University of South Carolina